Opaleye Management Reports Acquisition of $136,177.7221 in Grace Therapeutics Common Shares

Opaleye Management, a 10% owner of Grace Therapeutics, purchased 71,065 common shares. Purchases comprised 11,233 shares at $1.9349, 23,485 at $1.9453 and 36,347 at $1.8917. Indirect holdings through Opaleye, L.P. rose to 2,944,354 shares. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Grace Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-047473), on October 16, 2026, and is solely responsible for the information contained therein. (C)